Archives: Drug Cards

Benazepril Benazepril is a selective, competitive angiotensin‑converting enzyme (ACE) inhibitor widely used for arterial hypertension and post‑myocardial‑infarction (MI) therapy. Its pharmacologic profile includes a distinct active metabolite (benazepril‑β‑hydroxy acid) that potentiates the drug’s efficacy. Mechanism of Action Inhibits ACE: Blocks conversion of angiotensin‑I → angiotensin‑II, a potent vasoconstrictor and aldosterone‑stimulating peptide. Reduces Angiotensin‑II Levels: Decreases … Read more

Benadryl Benadryl (generic diphenhydramine) is a first‑generation, non‑selective antihistamine widely used for allergic reactions, urticaria, and as a short‑term sleep aid. — Mechanism of Action H1‑receptor blockade: competitively inhibits peripheral and central H1 receptors, dampening histamine‑mediated symptoms (urticaria, pruritus, rhinitis, bronchoconstriction). Anticholinergic activity: inhibits muscarinic receptors in the CNS and periphery, contributing to sedation, dry … Read more

Belsomra Mechanism of Action Selective ligand for the GABAA receptor subtype α3β2γ2. Acts as a partial agonist: Potentiates GABA‑mediated chloride influx → neuronal hyperpolarization. Produces a sedative effect with minimal influence on motor‑coordination or respiratory centers (low abuse liability). No affinity for opioid, dopamine, or serotonergic receptors. Pharmacokinetics Parameter Value Notes Absorption Oral, bioavailability ≈ … Read more

Bavencio Bavencio (atezolizumab) is a humanized monoclonal antibody that selectively binds to programmed death‑ligand 1 (PD‑L1), blocking its interaction with PD‑1 and CD80 on T cells. This restores antitumor T‑cell activity and is used primarily as an immune checkpoint inhibitor in several solid‑tumor malignancies. Mechanism of Action Bavencio functions as a PD‑L1 checkpoint inhibitor. Binding: … Read more

Basaglar Basaglar is a biosimilar biosynthetic human insulin glargine (300 U/mL) used as a long‑acting basal insulin in the management of type 1 and type 2 diabetes mellitus. Mechanism of Action Basaglar works by mimicking endogenous basal insulin secretion. Structure: Two arginine residues are added to the C‑terminus of the B‑chain and a glycine at the N‑terminus of … Read more

Baqsimi Baqsimi (sumatriptan acetate nasal spray) is an FDA‑approved, rapid‑acting treatment for acute migraine in adults and children aged 6–17 years. Mechanism of Action Selective agonist of 5‑HT1B and 5‑HT1D receptors Vasoconstriction of cranial meningeal arteries → reduces neurogenic inflammation Inhibition of trigeminal afferent neurotransmitter release (substance P, CGRP) → dampens pain signaling Rapid onset … Read more

I’m sorry, but I can’t find any reliable, clinically‑validated information on a drug called “Banzel.” If you meant a different medication (for example, a brand name, a generic name, or a drug in development), could you please provide more context or double‑check the spelling? Once I have a correct, verifiable drug name, I’ll gladly generate … Read more

Balsalazide Balsalazide is a synthetic 5‑aminosalicylic acid (5‑ASA) prodrug that delivers mesalamine specifically to the colon. It is widely used for the management of mild‑to‑moderate ulcerative colitis (UC) and, less commonly, for colonic Crohn’s disease. Mechanism of Action Balsalazide is an orally‑administered, enterohepatic‑stable prodrug that relies on colonic bacterial enzymes for activation. Prodrug structure: Two … Read more

Bactroban Bactroban is the commercial formulation of the topical antibiotic mupirocin. It is widely prescribed for superficial bacterial skin infections, predominantly caused by Staphylococcus aureus and Streptococcus pyogenes, including methicillin‑resistant S. aureus (MRSA). Mechanism of Action Inhibition of bacterial isoleucyl‑tRNA synthetase: Mupirocin binds competitively to the active site of this enzyme, preventing aminoacylation of tRNA¹³. … Read more

Bactrim Mechanism of Action Bactrim is a fixed‑ratio combination of trimethoprim (TMP) and sulfamethoxazole (SMX). Trimethoprim selectively inhibits bacterial dihydrofolate reductase (DHFR), blocking the conversion of dihydrofolate to tetrahydrofolate. Sulfamethoxazole is a structural analog of para‑aminobenzoic acid (PABA) and competitively inhibits dihydropteroate synthase (DHPS) in the folate synthesis pathway. The dual blockade creates a synergistic … Read more